Evidence map›Paper›PMID 38659460›Full record

ArticleFrontiers in psychiatry2024

Understanding the patient and supporter journey in cocaine use disorder.

Denise Leclair, Katherine M Waye, Baltazar Gomez-Mancilla, Brian D Kiluk, Ananda Krishna Karanam, Partha S Banerjee, Velusamy Shanmuganathan Muthusamy, Suzanne Maahs

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Denise LeclairNovartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, United States.
Katherine M WayeNovartis BioMedical Research, Cambridge, MA, United States.
Baltazar Gomez-MancillaNovartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
Brian D KilukYale School of Medicine, New Haven, CT, United States.
Ananda Krishna KaranamNovartis Healthcare Pvt. Ltd., Hyderabad, India.
Partha S BanerjeeNovartis Healthcare Pvt. Ltd., Hyderabad, India.
Velusamy Shanmuganathan MuthusamyNovartis Healthcare Pvt. Ltd., Hyderabad, India.
Suzanne MaahsNovartis BioMedical Research, Cambridge, MA, United States.
Novartis (India) · INNovartis (Switzerland) · CHNovartis (United States) · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is a paucity of literature describing experiences and journey of individuals with cocaine use disorder (CUD) and supporters who care for them. The aim of this study was to understand and document the journey of individuals with current CUD, those in CUD remission, and supporters. Methods: The online bulletin board (OBB) is a qualitative tool where participants engage in an interactive discussion on a virtual forum. After completing a 15-minute screening questionnaire determining eligibility, individuals in CUD remission and supporters participated in an OBB for 60 minutes, split across 8 days over 2 weeks. Individuals with current CUD participated in a one-time virtual focus group discussion for 90 minutes. Results: Individuals in CUD remission (n=35) were from Brazil, France, Spain, the UK, and the US; those with current CUD (n=5) and supporters (n=6) were from the US. Key insights were that individuals with current CUD were seeking a 'euphoric high' that cocaine provides. Those in CUD remission described a 'euphoric high' when they first tried cocaine, but over time it became harder to re-create this feeling. Individuals in CUD remission expressed a 'rollercoaster' of emotions from when they first started using cocaine to when they stopped. Supporters were sad, isolated, and worried about a potential cocaine overdose for their loved ones with CUD. Conclusion: The study provides valuable insights into the experiences and journey of individuals with CUD and their supporters. Data generated from this study gives insights into this under-served and growing population.

Indexed as

cocainecocaine use disorderjourneyonline bulletin boardpatient perspectivesqualitative researchsupporters

Identifiers

PMID38659460
PMCPMC11040082
OpenAlexW4394681164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.